Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Crocin + selenium is a **combination therapy** typically formulated as **nanoparticles** or physical mixtures intended for synergistic antioxidant and therapeutic effects. Crocin is a carotenoid compound found in saffron (*Crocus sativus*), known for its antioxidant, anti-inflammatory, neuroprotective, and anticancer properties, achieved by inhibiting monoamine oxidase (MAO) enzyme activity, blocking serotonin reuptake, modulating nuclear factor-kappa B pathway activity, and reducing pro-inflammatory cytokines[4]. Selenium, an essential trace element, functions pharmacologically as an antioxidant and immunomodulator by being incorporated into selenoproteins (including glutathione peroxidase and thioredoxin reductase), influencing oxidative stress, immune response, and cellular survival[5][6]. When combined, especially as crocin-conjugated selenium nanoparticles, the formulation shows enhanced efficacy in preclinical models for cancer via increased cytotoxicity and apoptosis induction, and in human studies has demonstrated improvement in cognitive impairment and antioxidant markers in multiple sclerosis patients[1][3]. Nanoparticle delivery (e.g., PEG-functionalized SeNPs) allows for targeted release, increased bioavailability, and reduction in side effects, establishing this combination as a promising approach for indications associated with oxidative stress or inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on crocin + selenium.